Detalhe da pesquisa
1.
KRAS4A induces metastatic lung adenocarcinomas in vivo in the absence of the KRAS4B isoform.
Proc Natl Acad Sci U S A
; 118(30)2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301865
2.
miR-203 drives breast cancer cell differentiation.
Breast Cancer Res
; 25(1): 91, 2023 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542268
3.
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas.
Proc Natl Acad Sci U S A
; 117(39): 24415-24426, 2020 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32913049
4.
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1.
Breast Cancer Res
; 23(1): 21, 2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579347
5.
Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma.
Genet Med
; 23(4): 698-704, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33442023
6.
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas.
J Pathol
; 251(4): 378-387, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462735
7.
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.
Breast Cancer Res
; 22(1): 124, 2020 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33176887
8.
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.
Int J Cancer
; 146(5): 1435-1444, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31335987
9.
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.
Mod Pathol
; 33(12): 2580-2590, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616874
10.
Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolution.
Invest Clin
; 57(2): 187-216, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28429898
11.
[Cadherins E and P expression in the molecular types of breast cancer]. / Expresión de cadherinas E y P en los tipos moleculares de cáncer de mama.
Invest Clin
; 56(2): 155-68, 2015 Jun.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26299056
12.
Distribution of PD-L1, TROP2 and HER2- "lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalation.
Clin Transl Oncol
; 26(5): 1273-1279, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851244
13.
Hepatic nutrient and hormone signaling to mTORC1 instructs the postnatal metabolic zonation of the liver.
Nat Commun
; 15(1): 1878, 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499523
14.
NGFR regulates stromal cell activation in germinal centers.
Cell Rep
; 43(2): 113705, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307025
15.
Cabergoline as a Novel Strategy for Post-Pregnancy Breast Cancer Prevention in Mice and Human.
Res Sq
; 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405932
16.
Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression.
Front Immunol
; 14: 1113858, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37033927
17.
PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer.
Am J Cancer Res
; 13(5): 2116-2125, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293154
18.
Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers.
Cell Death Differ
; 30(1): 37-53, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869285
19.
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas.
J Clin Invest
; 133(7)2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928090
20.
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.
Nat Commun
; 14(1): 1122, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854674